G/TBT/N/USA/1787  
12 October 2021  
(21-7710) Page: 1/2 
Committee on Technical Barriers to Trade  Original:  English  
 
  
NOTIFICATION  
The following notification is being circulated in accordance with Article 10.6  
 
1. Notifying Member:  UNITED STATES OF AMERICA   
If applicable, name of local government involved (Article 3.2 and 7.2):   
2. Agency responsible:  Food and Drug Administration (FDA), Health and Human Services 
(HHS) [1816]  
Name and address (including telephone and fax numbers , email and website 
addresses, if available) of agency or authority designated to handle comments 
regarding the not ification shall be indicated if different from above:   
Please submit comments to: USA WTO TBT Enquiry Point, Email: usatbtep@nist.gov  
3. Notified under Article 2.9.2 [   ], 2.10.1 [   ], 5.6.2 [   ], 5.7.1 [   ], other  [X]:  
4. Products covered (HS or CCCN where applicable, otherwise national tariff 
heading. ICS numbers may be provided in addition, where applicable):  Silver 
nitrate; Domestic safety (ICS 13.120), Production in the chemical industry (ICS 71.020), 
Inorganic chemicals (ICS 71.060)  
5. Title, number of pages and language(s) of the notified document:  Listing of Color 
Additives Exempt From Certification; Sil ver Nitrate (5 page(s), in English)  
6. Description of content:  Final rule - The Food and Drug Administration (FDA or we) is 
amending the color additive regulations to provide for the safe use of silver nitrate as a 
color additive in professional -use only cosmetics to color eyebrows and eyelashes. This 
action is in response to a color additive petition (CAP) filed by GW Cosmetics GmbH.  
7. Objective and rationale, including the nature of urgent problems where 
applicable:  Prevention of deceptive practices an d consumer protection; Protection of 
human health or safety  
8. Relevant documents:   
86 Federal Register (FR) 55494, 6 October 2021; Title  21 Code of Federal Regulations 
(CFR) Part 21 and 73:  
https://www.govinfo.gov/content/pkg/FR -2021-10-06/html/2021 -21755.htm  
https://www.govinfo.gov/content/pkg/FR -2021-10-06/pdf/2021 -21755.pdf  
This final rule is identified by Docket Number FDA -2018-C-0617. The Docket Folder is 
available on Regulations.gov at https://www.regulations.gov/docket/FDA -2018-C-
0617/document  and provides access to primary and supporting documents as well as 
comments received. Documents are also accessible from Regula tions.gov  by searching 
the Docket Number.   
This rule is effective 8 November 2021. See section VIII for further information on the 
filing of objections. Submit either electronic or written objections and requests for a 
hearing on the final rule by 5 Novemb er 2021. WTO Members and their stakeholders are 
asked to submit comments to the USA TBT Enquiry Point . Comments received by the USA G/TBT/N/USA/1787  
 
- 2 - 
 
  TBT Enquiry Point from WTO Members and their stakeholders will be shared with the 
regulator and will also be submitted to the Docket  on Regulations.gov if received within 
the comment period.  
9. Proposed date of adoption:  6 October 2021  
Proposed date of entry into force:  8 November 2021  
10. Final date for comments:  5 November 2021  
11. Texts available from:  National enquiry point [ ] or address, telephone and fax 
numbers and email and website addresses, if available , of other body:   
https://members.wto.org/crnattachments/2021/TBT/USA/21_6494_00_e.pdf